Study Summary
This trial is testing a new vaccine to see if it can prevent gonorrhea. The study will last 36 months and 2200 people will be enrolled.
- Gonorrhea
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 5 Secondary · Reporting Duration: Day 91 to Day 451
Trial Safety
Safety Progress
Side Effects for
Trial Design
2 Treatment Groups
Group 1
1 of 2
Group 2
1 of 2
Experimental Treatment
Non-Treatment Group
2200 Total Participants · 2 Treatment Groups
Primary Treatment: Meningococcal Group B Vaccine · Has Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 50 · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Has the United States Food and Drug Administration endorsed Meningococcal Group B Vaccine?
"An assessment of the Meningococcal Group B Vaccine's safety by our research team resulted in a rating of 2. This is due to Phase 2 trial data indicating its security, but there being no verifiable information demonstrating efficacy." - Anonymous Online Contributor
Is there an open enrollment period for this research study?
"As per clinicaltrials.gov, this trial is still recruiting participants. It was first made available on December 29th 2020 and the most recent edit occurred on November 23rd 2022." - Anonymous Online Contributor
In how many locales is this trial accessible?
"Patients can enroll in this research at 11 different sites, including the University of Pennsylvania HIV/AIDS Prevention Research Division in Philadelphia, Harlem Prevention Center, Columbia University Mailman School of Public Health in New York, and Emory University Hospital Midtown - Emory Clinic Infectious Diseases in Atlanta. Additionally, there are 7 other locations to choose from." - Anonymous Online Contributor
How many participants are eligible to partake in this experiment?
"To adequately conduct this trial, 2200 participants must meet its inclusion criteria. These volunteers may come from the University of Pennsylvania HIV/AIDS Prevention Research Division in Philadelphia or Harlem Prevention Center, Columbia University, Mailman School of Public Health in New York City." - Anonymous Online Contributor
Does the current protocol for this trial encompass elderly participants?
"This research initiative calls for participants aged between 18 and 50 years old. 203 trials are available to those under the age of majority, while 612 studies cater to patients above 65." - Anonymous Online Contributor
Am I able to join this clinical investigation?
"Patients between 18 and 50 years old, diagnosed with gonorrhea, are eligible to take part in this clinical trial. Approximately 2200 participants will be accepted for the study." - Anonymous Online Contributor